Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer
about
Evaluation of traditional medicines for neurodegenerative diseases using Drosophila modelsEvaluation of anticancer activity of celastrol liposomes in prostate cancer cells.Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells.TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis.Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.TMPRSS2-ERG fusion promotes prostate cancer metastases in bone.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells.Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells.Celastrol: A Spectrum of Treatment Opportunities in Chronic DiseasesCelastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells.The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.Ethnicity and ERG frequency in prostate cancer.Tumor growth attenuating effect of celastrol in systemic malignancies.
P2860
Q27027455-42A7EA4C-CCA2-4ECE-8293-5AEC1D22B55EQ34502573-25C04167-789A-4420-BBAB-775B6052AF61Q34628984-6BBE762F-AF12-4599-9AFE-96AB89455CE5Q35562982-E4F7A09D-C7BB-4226-8D30-0EEFC0D3B177Q35810293-CF28C3B5-0EA4-4CB8-AAC4-FA9B8AA18185Q37294250-CFA6C130-29F7-40C2-940D-0177832F2FDEQ37508596-A5BF38FB-8DA7-4CF6-83B1-8020A45B6606Q37641588-635908DD-86E8-4202-ACEB-7EB0F1983533Q37706996-E8295A12-9F29-440D-96FA-31CBFBCC69E0Q37727814-98260E45-7758-4447-A54C-DE363E9EE543Q38203779-DE45453D-82F0-4E3B-BFEB-A036DFFB012EQ38818143-E2AC20BD-C89B-49ED-8847-35E616FE1228Q38876792-9869BF97-288E-4041-BFA5-3227BE0EBA10Q38902498-C37664F0-A876-4104-AE9E-3A058FC57D24Q38997119-E82B1D5D-E1EC-4DC1-9D1B-EA3BE1D4C697Q39406168-C30E6ABA-1741-46AC-BFB6-16F50E8A79D9Q41016182-D2969D8B-FCA5-4068-BDD2-B7736E1D08F6Q42782654-9E3400E5-F949-4D97-BDAA-7AC4CE2E98CFQ46504038-45F8C756-1279-494D-9886-7D6ABC3AC784Q53118440-C5FF4F6B-45AB-4655-BAE7-B60F6C808DED
P2860
Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@ast
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@en
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@nl
type
label
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@ast
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@en
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@nl
prefLabel
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@ast
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@en
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@nl
P2093
P2860
P3181
P1433
P1476
Celastrol suppresses tumor cel ...... ene expressing prostate cancer
@en
P2093
Huixiang Ji
Jianghua Wang
Longjiang Shao
Olga Dakhov
Patricia Castro
Wenhao Shen
Yaoxia Bai
Zhansong Zhou
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0058391
P407
P577
2013-01-01T00:00:00Z